Ilaris
Ilaris ingredients
| Active ingredient | Strength |
|---|---|
| Canakinumab | 150 mg/mL |
What Ilaris is used for
The FDA lists the approved uses on the official label (below). In the EU, canakinumab is approved as Ilaris for:
Periodic fever syndromes Ilaris is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents and children aged 2 years and older: Cryopyrin-associated periodic syndromes Ilaris is indicated for the treatment of cryopyrin-associated periodic syndromes (CAPS) including: Muckle-Wells syndrome (MWS), Neonatal-onset multisystem inflammatory disease (NOMID) / chronic infantile neurological, cutaneous, articular syndrome (CINCA), Severe forms of familial cold autoinflammatory syndrome (FCAS) / familial cold urticaria (FCU) presenting with signs and symptoms beyond cold-induced urticarial skin rash. Tumour necrosis factor receptor associated periodic syndrome (TRAPS) Ilaris is indicated for the treatment of tumour necrosis factor (TNF) receptor associated periodic syndrome (TRAPS). Hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficie…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Ilaris
- Generic name
- Canakinumab
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Injection, Solution
- Given
- Subcutaneous
- FDA approval
- Biologic licence (BLA) BLA125319
- On the US market since
- 2016
Official information
- Ilaris prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Canakinumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Ilaris?
Ilaris (Canakinumab) is a specialist medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Ilaris?
Ilaris contains Canakinumab (150 mg/mL).
Is Ilaris approved in Europe?
The same active substance is approved in the EU as Ilaris.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA